Windlas Biotech consolidated net profit rises 150.68% in the March 2022 quarter

12 May 2022 , 05:13 PM

Net profit of Windlas Biotech rose 150.68% to Rs 14.79 crore in the quarter ended March 2022 as against Rs 5.90 crore during the previous quarter ended March 2021. Sales rose 14.34% to Rs 122.13 crore in the quarter ended March 2022 as against Rs 106.81 crore during the previous quarter ended March 2021. For the full year,net profit rose 140.62% to Rs 38.09 crore in the year ended March 2022 as against Rs 15.83 crore during the previous year ended March 2021. Sales rose 8.96% to Rs 465.93 crore in the year ended March 2022 as against Rs 427.60 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	122.13	106.81	14	465.93	427.60	9
OPM %	11.33	10.41	–	11.25	12.75	–
PBDT	16.56	11.58	43	57.71	56.33	2
PBT	13.66	8.23	66	45.57	43.36	5
NP	14.79	5.90	151	38.09	15.83	141

Powered by Capital Market – Live News